AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.

AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.

AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.

AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.

Patients can learn how to take control of arthritis with a series of seminars on three different types of arthritis at the University of Alabama at Birmingham (UAB) Highlands Hospital during May, which is Arthritis Awareness Month. The seminars are presented by UAB bone and joint specialists and the Arthritis Foundation.